B4GALNT3-CCDC77 Fusion FISH Probe
The B4GALNT3-CCDC77 Fusion FISH Probe is used to confirm a fusion of the B4GALNT3 and CCDC77 genes. The fusion of the B4GALNT3 and CCDC77 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| B4GALNT3-CCDC77-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-RERE | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-REOR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-REGO | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-REGR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-OROR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GORE | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GROR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| B4GALNT3-CCDC77-20-AQAQ | 20 (40 μL) | 200 μL |
|
CCDC77 Gene Summary
The Coiled-coil Domain Containing 77 (CCDC77) gene is located on chr12 :498515-551806 at 12p13.33.
Gene Name: Coiled-coil Domain Containing 77
Chromosome: CHR12: 498515 -551806
Locus: 12p13.33
B4GALNT3 Gene Summary
B4GALNT3 transfers N-acetylgalactosamine (GalNAc) onto glucosyl residues to form N,N-prime-diacetyllactosediamine (LacdiNAc, or LDN), a unique terminal structure of cell surface N-glycans (Ikehara et al., 2006 [PubMed 16728562]).[supplied by OMIM, Aug 2008]
Gene Name: Beta-1,4-N-acetyl-galactosaminyltransferase 3
Chromosome: CHR12: 569542 -671058
Locus: 12p13.33
Gene Diseases
The B4GALNT3 CCDC77 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|